Reuters logo
8 months ago
BRIEF-Janssen submits two applications to FDA seeking approval of Simponi Aria
December 20, 2016 / 9:56 PM / 8 months ago

BRIEF-Janssen submits two applications to FDA seeking approval of Simponi Aria

Dec 20 (Reuters) - Johnson & Johnson :

* Janssen biotech - data from two separate phase 3 studies evaluating efficacy and safety of simponi aria 2 served as basis for submissions

* Janssen submits two applications to fda seeking approval of simponi aria (golimumab) for the treatment of active psoriatic arthritis and active ankylosing spondylitis Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below